Compare UXIN & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UXIN | YDES |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | China | Taiwan |
| Employees | N/A | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 756.6M | 894.2M |
| IPO Year | 2018 | N/A |
| Metric | UXIN | YDES |
|---|---|---|
| Price | $3.53 | $6.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 115.6K | 11.4K |
| Earning Date | 03-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $237.18 | N/A |
| Revenue Next Year | $145.46 | N/A |
| P/E Ratio | $4.05 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.45 | $5.40 |
| 52 Week High | $5.40 | $25.00 |
| Indicator | UXIN | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 50.10 | 48.51 |
| Support Level | $3.21 | N/A |
| Resistance Level | $3.83 | $9.46 |
| Average True Range (ATR) | 0.19 | 0.70 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 45.16 | 77.25 |
Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.